Nineteen patients with high-risk resected stage III and IV melanoma were immunized with three tumor antigen epitope peptides from gp100, MART-1, and tyrosinase emulsified with adjuvant Montanide ISA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback